QA: Impax Laboratories LLC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001003642_2018_Impax_Laboratories_LLC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001003642, Impax Laboratories LLC

  xvar xval
0 AssetsCurrent 695,555,000
1 IntangibleAssetsNetIncludingGoodwill 469,767,000
2 PropertyPlantAndEquipmentNet 124,813,000
3 remainder_Assets 61,165,000
4 LiabilitiesCurrent 354,238,000
5 LiabilitiesNoncurrent 806,635,000
6 remainder_Liabilities 3,226,000
7 CostOfGoodsAndServicesSold 530,723,860
8 SellingGeneralAndAdministrativeExpense 227,371,828
9 ResearchAndDevelopmentExpense 80,833,932
10 remainder_Expenses 637,632,553
11 remainder_Revenues 783,734,605
12 remainder_NetIncome 5,763,051
13 remainder_ComprehensiveNetIncome 12,011,719
  yvar yval
0 Assets 1,351,300,000
1 Liabilities 1,164,099,000
2 Expenses 1,476,562,173
3 Revenues 783,734,605
4 StockholdersEquity 187,201,000
5 NetIncome -687,064,517
6 ComprehensiveNetIncome -681,058,658
7 BaseVar 2,396,735,274
8 EconomicCapitalRatiobeforeLimitedLiability -0.217
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time